Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The global average gross margin of specialty drug distribution is in the decreasing trend, from 7.85% in 2011 to5.97% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.

The type of specialty drugs includes oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of oncology drugs in 2015 is about 45.8%, and the proportion of rheumatoid arthritis drug in 2015 is about 15.4%.

Specialty drugs are widely sold by retail, home health, clinics, and pharmacies. The most proportion of specialty drugs are sold by clinics and the market share in 2015 is about 37.6%.

North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 45.6% in 2015. Europe is the second largest supplier of specialty drug distribution, enjoying sales revenue market share about 31.7% in 2015.

Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, Celesio, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.


According to this study, over the next five years the Specialty Drug Distribution market will register a 12.0% CAGR in terms of revenue, the global market size will reach USD 1270 million by 2024, from USD 640 million in 2019. In particular, this report presents the global revenue market share of key companies in Specialty Drug Distribution business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Specialty Drug Distribution market by product type, application, key companies and key regions.

This study considers the Specialty Drug Distribution value generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oncology
Rheumatoid Arthritis
Hemophilia
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Retail
Home Health
Clinics
Pharmacies

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Specialty Drug Distribution market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Specialty Drug Distribution market by identifying its various subsegments.
Focuses on the key global Specialty Drug Distribution players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Specialty Drug Distribution with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Specialty Drug Distribution submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.